MedTrace Logo

Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16

NCT05740163 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-10

No results posted yet for this study

Summary

The aim of the study is to determine the efficacy of a 12-month egg oral immunotherapy (OIT) protocol with a cooked whole egg product including yolk and egg white.

Study hypothesis: With this method the risk for severe allergic reaction to egg protein is reduced and the diet can partly or completely be normalized.

Conditions

  • Egg Allergy

Interventions

DIETARY_SUPPLEMENT

Egg product including egg white and yolk allergens

Egg product either meatball or bread roll or bun including egg white and yolk allergens delivered orally in increasing dosages daily.

Sponsors & Collaborators

  • University of Oulu

    collaborator OTHER

  • Oulu University Hospital

    collaborator OTHER

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Rüdiger Schultz, MD., PhD · Tampere University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-30
Primary Completion
2024-12-31
Completion
2026-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05740163 on ClinicalTrials.gov